Primer on Tumor Immunology and Biological Therapy of Cancer

Last Modified: March 20, 2008

Conference Dates: October 30, 2008
Conference Location: Westin Horton Plaza- San Diego, CA

Sponsoring Group: International Society for Biological Therapy of Cancer

Conference Web Page URL: http://www.isbtc.org/meetings/am08/primer08/

Topics Covered:

  • Adoptive T Cell Therapy
  • Anti-Angiogenic Therapies
  • Antibody Therapy of Cancer
  • Approach to Identifying and Therapeutic Exploitation of Tumor Antigens
  • Blocking Anti-T Cell Checkpoints
  • Cytokines
  • Immune Adjuvants
  • Inflammation and Cancer Immunotherapy
  • Mechanisms of Immune-Mediated Tumor Lysis
  • T Reg Cells

Conference Objectives: This primer will provide a current overview of immunology as it applies to cancer etiology, biology and therapy. The target audience for this program is basic and clinical investigators from academic, regulatory, and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows, and allied health professionals.

Who Should Attend: clinicians, researchers, students, post-doctoral fellows, and allied health professionals.

Registration Information: Registration for the iSBTc 23rd Annual Meeting and Associated Programs begins on May 1, 2008. Registration will be available online or through an order form. iSBTc Members receive reduced registration fees for all educational programs. All non-members have the opportunity to submit applications for membership and receive reduced registration fees as well.

Continuing Education: Yes

Blogs

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015

Related News

Patients with rheumatoid arthritis treated with biologic agents have similar cancer survival rate

Feb 8, 2011

Patients with rheumatoid arthritis treated with biologic agents have similar cancer survival rate


Melanoma Risk Up in IBD Independent of Biologic Therapy

Feb 3, 2014

Meta-analysis based on cohort studies finds link between IBD and increased risk of melanoma


Therapy-Related Leukemia Risk Varied From 1975 to 2008

Feb 19, 2013

Risk after chemotherapy varies depending on initial cancer and treatment practices